bioMérieux strengthens its Clostridium difficile offer with the launch of VIDAS® C. difficile GDH
BioFire Submits 510(k) Application to FDA for FilmArray® Gastrointestinal Panel
bioMérieux’s THxID®-BRAF Test for Detection of 2 BRAF Mutations V600E and V600K in Late-Stage Metastatic Melanoma adopted by Clarient, a GE Healthcare Company
bioMérieux review for the year ended December 31, 2013
bioMérieux finalizes acquisition of the U.S. company BioFire, specialized in molecular biology
EMSL makes the decision to implement the bioMérieux VITEK MS
BacT/ALERT® Reagent Status
View 2013 CLINICAL Solutions Catalog
View 2013 INDUSTRY Food Catalog
View 2013 INDUSTRY Pharma Catalog
DVT Awareness Month
Are you using the right D-dimer assay to safely exclude VTE patients?
For the latest VITEK® 2 information, go to the VITEK® 2 microsite, customer login required.
Bacteriophage Technology in Food Testing
Sepsis Education: KnowFromDay1